EMEA-000181-PIP02-13

Key facts

Active substance
  • Cannabidiol
  • delta-9-tetrahydrocannabinol
Therapeutic area
Neurology
Decision number
P/0298/2014
PIP number
EMEA-000181-PIP02-13
Pharmaceutical form(s)
Oromucosal spray
Condition(s) / indication(s)
Treatment of pain
Route(s) of administration
Oromucosal use
Contact for public enquiries
GW Pharma Ltd

United Kingdom
Tel. +44 (0)1223 266800
Fax +44 (0)1223 235667
E-mail: medinfo@gwpharm.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating
Average
1 rating
1 rating